Metiscan’s Outpatient Diagnostic Imaging Facility Upgrades to Web 2.0 EHR System

DALLAS, TX–(Marketwire – August 5, 2010) – Metiscan’s (PINKSHEETS: MTIZ) majority owned subsidiary Schuylkill Open MRI, Inc. (Schuylkill), which is an outpatient diagnostic imaging facility located in Pottsville, Pennsylvania providing Magnetic Resonance Imaging (MRI) services, announced today that it has upgraded its legacy electronic healthcare records (EHR) system to a new Web 2.0 based Health Language Seven (HL7) compliant EHR and practice management system.

The new EHR system enhances practice workflow, improving operational efficiencies which management believes will increase cost savings and aid the center’s staff in providing high quality patient care. The EHR system enables Schuylkill to operate as a virtually paper free and filmless practice and includes features such as patient scheduling, practice management and the electronic archiving and distribution of high-quality MRI images and patient reports. Secure access is available to radiologists and referring physicians from any location having a web-browser and a broadband connection.

Schuylkill historically licensed the use of its former EHR system. Since 2003, Schuylkill has paid a licensing fee on a per-study basis. Going forward Schuylkill has determined to purchase its own EHR system and retain FirstView EHR, Inc. (FirstView), which is also a majority owned subsidiary of Metiscan, to host and administer the system. Purchasing the new EHR system provides Schuylkill with a productivity tool that embraces today’s latest secure web technologies and eliminates the need to pay a third party a license fee on a per-study basis.

About Schuylkill Open MRI, Inc.
Schuykill Open MRI, Inc. (Schuylkill) is an outpatient diagnostic facility located in Pottsville, Pennsylvania providing Magnetic Resonance Imaging (MRI) services. Schuylkill began operations in March 2003 and currently performs MRI exams on a Siemens OPEN MRI platform and a Siemens 1.5T high-field MRI platform. Having both platforms provides Schuylkill flexibility in the studies it can conduct. Schuylkill participates in most major insurance plans and accepts Medicare, Medicaid, Worker’s Compensation claims, Personal Injury Protection (PIP) and Letters of Protection (LOPs). Schuylkill is accredited by the American College of Radiology (ACR) and is a majority owned subsidiary of Metiscan, Inc. 

Safe Harbor Statement: Certain of the statements made in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause Metiscan’s actual results to be materially different from the historical results or from any future results expressed or implied by such forward-looking statements. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms “believes,” “belief,” “intends,” “anticipates” or “plans” to be uncertain and forward-looking. The Company does not intend to update any of the forward-looking statements after the date of this release to conform these statements to actual results or to changes in its expectations, except as may be required by law.

Click here to see all recent news from this company